# AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-17 11:29 UTC · Category: Business · Sources: 8 · Current Velocity: 5.66

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| FirstWord Pharma | AstraZeneca suffers blow as pivotal lung cancer study of volrustomig halted | 2026-08-17 13:07 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE5PYlFoMWhRSEdLWGE3STBsNnNKaUtVWWtEdlhmazJfdDdEY0JkcTZZb081alNOSmFRNVJ2VHdPRzB5YVI2UG5kT21SbkQ2cl9JQ0hZ?oc=5) |
| BioPharma Dive | AstraZeneca scraps Phase 3 trial of new bispecific in lung cancer | 2026-08-17 09:25 | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxONWdkRHJUNTR5bFdUSzRFN1RFTVlkWk9NVFhCZFpIaTZzVlp2QUxwMktDNzJ1UFN2aWNNWVdpdktVdk5oOXhDZEhlbmdxSXRrMWJ1UmFnVTRLa0pzZy1JV1E0Mm1NSGJfZm82V1ZOVnlYUWJrbGdlV0ZZaEg1QUhyUWkyYjRlR3FoOGoyZ2hTYWFaYkRPcE1YWXd3dW9KQQ?oc=5) |
| Endpoints News | AstraZeneca cans late-stage bispecific trial after lung cancer setback | 2026-08-17 09:25 | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxPRlYwMUZ2WmNTU1pxcUR6bkFaNll3TVRXT1lvaDhfUVdtZzB4RGtiMTNURjBFVTkyUXF0M3o0Q3JMQTMwdmh0a25walp2UVhjc1NmcFZNZXAzS256RW5MTnBQYVhzREU4a3FxdF9VdXpVazE5WERONUpVSkJRcVEyZ1BFeV94S0Jja1VVamNfeTFLSzJmMlRnaDlFOA?oc=5) |
| The Times | AstraZeneca posts two wins and a setback for lung cancer pipeline | 2026-08-17 09:25 | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxQempSRUF6TFU5UG1IcEIwTGdCT2FDc2p1Vk94WDRHdFkwOVA3djNrbjlJMl9Vc2x1Uy1zcHVMeHQ5VlI0WVFoWkl4UEVDcXh5U293N3c3U1N1bDQzMjBkUlB3VUlTZzBKVmYtTGxkczV6NUtEaVdnemZMTmp0V0xidHRfNDdTeS15RmlaSU56MUt4RlBVN0ZBdWVsbUFqUTB4?oc=5) |
| Reuters | AstraZeneca suffers another setback as it halts volrustomig lung cancer trial | 2026-08-17 09:25 | [Source Link](https://news.google.com/rss/articles/CBMi0gFBVV95cUxQSXVnTkltTjBiMG84WjZvanR3Y0FqM0ZEMW11MWtkZVZLaUdJdDRVN1lwMDZmMkREQllXT1EzZ1hDM2l5dFQ5OVlIWlY0b2hZTDNuLXExRFNYdDdQeGlYdGpvWHZXQjVjSmVZcE43U1ZIMkNoNjlFMVhMbzliZVNnLTZhZjFwU0dCX3NSeEpoQUt6RmxYa3NwX2dET0Jaa3J6eF9WYU93WlpNNEZqRmlieU1aYndONGZZcW1JTEFNVGVlZkluM0FmaUFpUDRfXzMtSXc?oc=5) |
| Bloomberg.com | AstraZeneca Stops Cancer Drug Trial as Success Seen Unlikely | 2026-08-17 09:25 | [Source Link](https://news.google.com/rss/articles/CBMirAFBVV95cUxQV3drR0RZZlJhbkVUNHkzNjhibno2ZnZTOVBFNC1ualYyRy1NYmNMc1pHQlVIbEJzcmx6eC12U1Z4cnFIUG9zVlhQUWFnanI4dnA5a0p1eXJ3a3c3QXRNVVZVOHdIeWZpamlmS2ozd1FjSHZYS1dfdVJhX1dFeXpMajZaMmpsRW9nczR1aFo2NTkzZVM5N3dtblFuOVFxM0xhZmNWai10elVFMUZ1?oc=5) |
| AstraZeneca | Update on eVOLVE-Lung02 Phase III trial of volrustomig plus chemotherapy in metastatic non-small cell lung cancer | 2026-08-17 09:25 | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxNVUlleDBnQmFlTEVxdFNJOHNzVmdZUTI3WDZMWWZocElKdzhYQi16ejFDUmpLbUFod0FJdjBSODg1dmhPYUdxbDdEXzZZU2RGa1NXWmx4WTBtZ1Vxc0p4MTRRVVhkaV80WUNxVFRYVGxBbW5GZ1pzUHVDZURCM2VXbmI3LWZfMlVEWVZTWjhUcGw5SXdyUVlwUzFXMktnaldOMGdJN2NrN1I?oc=5) |
| WSJ | AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review | 2026-08-17 09:25 | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTFRONjBRZlJ6WHJHXzkwbTBUNWZqRUlubzFlSU4wdUVValVxMm5oaTFHZGhQNnEwaVZkeUZuZVUtTzN1SDlpdUt3Y0xuV2lwblpWQ2Z1TWJCSU9GaXZEcHdzTzJuYXV3UVZ0MEM2YVpnUnkyZ0Izb1hQNjRIOExMLUt2MmJELUlndjdJSG9ZS2hDRU5QTWh6U0RtZnlGQmNHVmJCVXlMblRXMG8?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-17/astrazeneca-ends-phase-3-lung-cancer-drug-trial-after-review*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*